{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:55:33Z","timestamp":1768784133662,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jgar.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:54:29Z","timestamp":1557834869000},"page":"228-230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Drug susceptibility profile of Mycobacterium kansasii clinical isolates from Brazil"],"prefix":"10.1016","volume":"19","author":[{"given":"Luciana Dist\u00e1sio","family":"de Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Carvalho","family":"de Queiroz Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Redner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo Dias","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Cesar","family":"de Souza Caldas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"da Silva Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus Pais","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jgar.2019.05.003_bib0005","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1469-0691.2009.03014.x","article-title":"Clinical manifestations of non-tuberculous mycobacteria infections","volume":"15","author":"Tortoli","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"44","key":"10.1016\/j.jgar.2019.05.003_bib0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3109\/00365548.2012.694469","article-title":"Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London","volume":"11","author":"Davies","year":"2012","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2019.05.003_bib0015","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5588\/ijtld.12.0237","article-title":"Epidemiology and clinical significance of non-tuberculous mycobacteria isolated from pulmonary specimens","volume":"17","author":"Braun","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"10.1016\/j.jgar.2019.05.003_bib0020","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of non-tuberculous mycobacteria isolated from pulmonary samples: a NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jgar.2019.05.003_bib0025","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.3389\/fmicb.2016.02097","article-title":"Mycobacterium kansasii subtype I is associated with clarithromycin resistance in China","volume":"7","author":"Li","year":"2016","journal-title":"Front Microbiol"},{"issue":"19","key":"10.1016\/j.jgar.2019.05.003_bib0030","first-page":"393","article-title":"Clinical and therapeutic features of pulmonary non-tuberculous mycobacterial disease, Brazil, 1993\u20132011","volume":"3","author":"Mello","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.jgar.2019.05.003_bib0035","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1164\/ajrccm.175.7.744b","article-title":"Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases: an official ATS\/IDSA statement","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jgar.2019.05.003_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/microbiolspec.TNMI7-0011-2016","article-title":"Mycobacterium kansasii","volume":"5","author":"Johnston","year":"2017","journal-title":"Microbiol Spectr"},{"issue":"11","key":"10.1016\/j.jgar.2019.05.003_bib0045","first-page":"705","article-title":"Mycobacterium kansasii, species or complex? Biomolecular and epidemiological insights","volume":"78","author":"Tortoli","year":"2003","journal-title":"Kekkaku"},{"key":"10.1016\/j.jgar.2019.05.003_bib0050","volume":"1","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.jgar.2019.05.003_bib0055","first-page":"1","volume":"48","author":"Brasil\/Minist\u00e9rio da Sa\u00fade\/Secretaria de Vigil\u00e2ncia em Sa\u00fade","year":"2017"},{"issue":"2","key":"10.1016\/j.jgar.2019.05.003_bib0060","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1089\/mdr.2015.0134","article-title":"In vitro antimicrobial susceptibility of nontuberculous mycobacteria in Iran","volume":"22","author":"Heidarieh","year":"2016","journal-title":"Microb Drug Resist"},{"issue":"Pt 10","key":"10.1016\/j.jgar.2019.05.003_bib0065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1099\/jmm.0.45965-0","article-title":"Mycobacterium kansasii: antibiotic susceptibility and PCR restriction analysis of clinical isolates","volume":"54","author":"da Silva Telles","year":"2005","journal-title":"J Med Microbiol"},{"issue":"3","key":"10.1016\/j.jgar.2019.05.003_bib0070","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkp238","article-title":"Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan","volume":"64","author":"Wu","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.05.003_bib0075","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/jac\/dki111","article-title":"In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii","volume":"55","author":"Guna","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.jgar.2019.05.003_bib0080","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijantimicag.2009.09.023","article-title":"In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands","volume":"35","author":"Van Ingen","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2019.05.003_bib0085","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2015.12.007","article-title":"The antimicrobial susceptibility of non-tuberculous mycobacteria","volume":"72","author":"Cowman","year":"2016","journal-title":"J Infect"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519301134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519301134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:53:03Z","timestamp":1761990783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519301134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":17,"alternative-id":["S2213716519301134"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.05.003","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug susceptibility profile of Mycobacterium kansasii clinical isolates from Brazil","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}